Issued Patents 2020
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10836744 | Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity | Daniel H. Byun, Yan Chen, Melissa Fleury, John R. Jacobsen, Eric L. Stangeland +2 more | 2020-11-17 |
| 10829438 | Neprilysin inhibitors | Melissa Fleury | 2020-11-10 |
| 10759813 | Neprilysin inhibitors | Roland Gendron | 2020-09-01 |
| 10752599 | Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof | Melissa Fleury, Miroslav Rapta, Venkat R. Thalladi, Gene Timothy Fass, Michael Simeone | 2020-08-25 |
| 10744104 | Neprilysin inhibitors | Erik Fenster, Melissa Fleury, Roland Gendron, Edmund J. Moran | 2020-08-18 |
| 10590107 | Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity | Daniel H. Byun, Yan Chen, Melissa Fleury, John R. Jacobsen, Eric L. Stangeland +2 more | 2020-03-17 |
| 10570120 | Neprilysin inhibitors | Melissa Fleury | 2020-02-25 |
| 10548879 | (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid | Melissa Fleury, Anne-Marie Beausoleil, Erik Fenster, Venkat R. Thalladi, Miroslav Rapta | 2020-02-04 |